inducTION of mage‐A3 and HPV‐16 immunity by Trojan vaccines in patients with head and neck carcinoma
Head & Neck2012Vol. 34(12), pp. 1734–1746
Citations Over TimeTop 10% of 2012 papers
Caroline Voskens, Duane A. Sewell, Ronna Hertzano, Jennifer DeSanto, Sandra Rollins, Myoung-Hee Lee, R. Taylor, Jeffrey S. Wolf, Mohan Suntharalingam, Brian Gastman, John C. Papadimitriou, Changwan Lu, Ming Tan, Robert E. Morales, Kevin J. Cullen, Esteban Celis, Dean L. Mann, Scott E. Strome
Abstract
This treatment regimen seems to have acceptable toxicity and elicits measurable systemic immune responses against HLA-II restricted epitopes in a subset of patients with advanced SCCHN.
Related Papers
- → Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme(2003)81 cited
- → Selective and potent furin inhibitors protect cells from anthrax without significant toxicity(2010)41 cited
- → Interaction of Mint3 with Furin regulates the localization of Furin in the trans-Golgi network(2008)32 cited
- → Development and characterisation of an assay for furin activity(2010)28 cited
- → Blockade of Furin Activity and Furin-Induced Tumor Cells Malignant Phenotypes By The Chemically Synthesized Human Furin Prodomain(2010)22 cited